Capital Fund Management S.A. Amgen Inc Call Options Transaction History

Capital Fund Management S.A.

$33.5 Billion
Q1 2025

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2025 May 14, 2025	BUY	$258.59 - $327.36 $35.3 Million - $44.7 Million	136,600 Added 143.34%	231,900 $72.2 Million
Q4 2024 Feb 13, 2025	SELL	$258.78 - $328.31 $20.4 Million - $25.9 Million	-78,800 Reduced 45.26%	95,300 $24.8 Million
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $29.5 Million - $32.1 Million	-95,200 Reduced 35.35%	174,100 $56.1 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $10.5 Million - $12.8 Million	-40,100 Reduced 12.96%	269,300 $84.1 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $32 Million - $38.7 Million	119,200 Added 62.67%	309,400 $88 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $18 Million - $20.2 Million	-70,200 Reduced 26.96%	190,200 $54.8 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $27.5 Million - $34.1 Million	-125,600 Reduced 32.54%	260,400 $70 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $40.3 Million - $47.6 Million	187,900 Added 94.85%	386,000 $85.7 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $41 Million - $49.9 Million	181,500 Added 1093.37%	198,100 $47.9 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $2.36 Million - $3 Million	-10,300 Reduced 38.29%	16,600 $4.36 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $695,826 - $784,765	-3,100 Reduced 10.33%	26,900 $6.06 Billion
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $2.15 Million - $2.39 Million	9,300 Added 44.93%	30,000 $7.3 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $4.84 Million - $5.36 Million	20,700 New	20,700 $5.05 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $3.82 Million - $4.45 Million	-17,200 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $2.36 Million - $2.81 Million	-10,900 Reduced 38.79%	17,200 $3.95 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $11.4 Million - $12.7 Million	-48,600 Reduced 63.36%	28,100 $7.14 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $19.6 Million - $24.1 Million	-99,100 Reduced 56.37%	76,700 $18.1 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $13.7 Million - $18.2 Million	75,100 Added 74.58%	175,800 $35.6 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $18.5 Million - $23.8 Million	97,900 Added 3496.43%	100,700 $24.3 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $6.79 Million - $8.14 Million	-39,000 Reduced 93.3%	2,800 $542,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $6.1 Million - $6.87 Million	32,900 Added 369.66%	41,800 $8.67 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $996,300 - $1.12 Million	-6,000 Reduced 40.27%	8,900 $1.64 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $220,259 - $257,400	1,300 Added 9.56%	14,900 $2.54 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $3.61 Million - $4.04 Million	-21,400 Reduced 61.14%	13,600 $2.37 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $5.86 Million - $6.69 Million	35,000	35,000 $6.53 Million

Others Institutions Holding AMGN

# of Institutions

3,288

Shares Held

426M

Call Options Held

7.45M

Put Options Held

7.46M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $161B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account